| Year |
Citation |
Score |
| 2024 |
Sun Z, Kwon JS, Ren Y, Chen S, Walker CK, Lu X, Cates K, Karahan H, Sviben S, Fitzpatrick JAJ, Valdez C, Houlden H, Karch CM, Bateman RJ, Sato C, et al. Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming. Science (New York, N.Y.). 385: adl2992. PMID 39088624 DOI: 10.1126/science.adl2992 |
0.585 |
|
| 2023 |
Horie K, Salvadó G, Barthélemy NR, Janelidze S, Li Y, He Y, Saef B, Chen CD, Jiang H, Strandberg O, Pichet Binette A, Palmqvist S, Sato C, Sachdev P, Koyama A, et al. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nature Medicine. PMID 37443334 DOI: 10.1038/s41591-023-02443-z |
0.632 |
|
| 2023 |
Sun Z, Kwon JS, Ren Y, Chen S, Cates K, Lu X, Walker CK, Karahan H, Sviben S, Fitzpatrick JAJ, Valdez C, Houlden H, Karch CM, Bateman RJ, Sato C, et al. Endogenous recapitulation of Alzheimer's disease neuropathology through human 3D direct neuronal reprogramming. Biorxiv : the Preprint Server For Biology. PMID 37292658 DOI: 10.1101/2023.05.24.542155 |
0.589 |
|
| 2023 |
Barthélemy NR, Saef B, Li Y, Gordon BA, He Y, Horie K, Stomrud E, Salvadó G, Janelidze S, Sato C, Ovod V, Henson RL, Fagan AM, Benzinger TLS, Xiong C, et al. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease. Nature Aging. 3: 391-401. PMID 37117788 DOI: 10.1038/s43587-023-00380-7 |
0.552 |
|
| 2023 |
Horie K, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Benzinger TLS, Fagan AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, Ikeuchi T, Kasuga K, Noble J, ... ... Sato C, et al. Change in cerebrospinal fluid tau microtubule binding region detects symptom onset, cognitive decline, tangles, and atrophy in Dominantly Inherited Alzheimer's Disease. Annals of Neurology. PMID 36843330 DOI: 10.1002/ana.26620 |
0.551 |
|
| 2022 |
Mahali S, Martinez R, King M, Verbeck A, Harari O, Benitez BA, Horie K, Sato C, Temple S, Karch CM. Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration. Translational Psychiatry. 12: 508. PMID 36494352 DOI: 10.1038/s41398-022-02274-5 |
0.311 |
|
| 2022 |
Horie K, Barthélemy NR, Spina S, VandeVrede L, He Y, Paterson RW, Wright BA, Day GS, Davis AA, Karch CM, Seeley WW, Perrin RJ, Koppisetti RK, Shaikh F, Lago AL, ... ... Sato C, et al. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. Nature Medicine. PMID 36424467 DOI: 10.1038/s41591-022-02075-9 |
0.555 |
|
| 2022 |
Capano LS, Sato C, Ficulle E, Yu A, Horie K, Kwon JS, Burbach KF, Barthélemy NR, Fox SG, Karch CM, Bateman RJ, Houlden H, Morimoto RI, Holtzman DM, Duff KE, et al. Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons. Cell Stem Cell. 29: 918-932.e8. PMID 35659876 DOI: 10.1016/j.stem.2022.04.018 |
0.566 |
|
| 2022 |
Lim YY, Maruff P, Barthélemy NR, Goate A, Hassenstab J, Sato C, Fagan AM, Benzinger TLS, Xiong C, Cruchaga C, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, et al. Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease. Jama Neurology. PMID 35099506 DOI: 10.1001/jamaneurol.2021.5181 |
0.554 |
|
| 2021 |
Ezerskiy LA, Schoch KM, Sato C, Beltcheva M, Horie K, Rigo F, Martynowicz R, Karch CM, Bateman RJ, Miller TM. Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction. Jci Insight. PMID 34874917 DOI: 10.1172/jci.insight.152012 |
0.491 |
|
| 2021 |
Sato C, Mallipeddi N, Ghoshal N, Wright BA, Day GS, Davis AA, Kim AH, Zipfel GJ, Bateman RJ, Gabelle A, Barthélemy NR. MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology. Annals of Clinical and Translational Neurology. PMID 34342183 DOI: 10.1002/acn3.51435 |
0.525 |
|
| 2021 |
Horie K, Barthélemy NR, Sato C, Bateman RJ. Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease. Brain : a Journal of Neurology. PMID 34215872 DOI: 10.1093/brain/awab227 |
0.535 |
|
| 2020 |
Horie K, Barthélemy NR, Sato C, Bateman RJ. CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease. Brain : a Journal of Neurology. PMID 33283854 DOI: 10.1093/brain/awaa373 |
0.573 |
|
| 2020 |
Horie K, Barthélemy NR, Mallipeddi N, Li Y, Franklin EE, Perrin RJ, Bateman RJ, Sato C. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain. Acta Neuropathologica Communications. 8: 149. PMID 32854776 DOI: 10.1186/S40478-020-01019-Z |
0.602 |
|
| 2020 |
Barthélemy NR, Horie K, Sato C, Bateman RJ. Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease. The Journal of Experimental Medicine. 217. PMID 32725127 DOI: 10.1084/Jem.20200861 |
0.586 |
|
| 2020 |
Xu Y, Du S, Marsh JA, Horie K, Sato C, Ballabio A, Karch CM, Holtzman DM, Zheng H. TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading. Molecular Psychiatry. PMID 32366951 DOI: 10.1038/S41380-020-0738-0 |
0.578 |
|
| 2020 |
Barthélemy NR, Bateman RJ, Hirtz C, Marin P, Becher F, Sato C, Gabelle A, Lehmann S. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification. Alzheimer's Research & Therapy. 12: 26. PMID 32183883 DOI: 10.1186/S13195-020-00596-4 |
0.602 |
|
| 2020 |
Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, ... ... Sato C, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z |
0.618 |
|
| 2019 |
Paterson RW, Gabelle A, Lucey BP, Barthélemy NR, Leckey CA, Hirtz C, Lehmann S, Sato C, Patterson BW, West T, Yarasheski K, Rohrer JD, Wildburger NC, Schott JM, Karch CM, et al. SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases. Nature Reviews. Neurology. PMID 31222062 DOI: 10.1038/S41582-019-0222-0 |
0.738 |
|
| 2019 |
Barthélemy NR, Mallipeddi N, Moiseyev P, Sato C, Bateman RJ. Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer's Disease. Frontiers in Aging Neuroscience. 11: 121. PMID 31178717 DOI: 10.3389/Fnagi.2019.00121 |
0.618 |
|
| 2019 |
Barthelemy NR, Mallipeddi N, Sato C, Bateman R. TAU PHOSPHORYLATION RATES CHANGE FROM BRAIN TO CEREBROSPINAL FLUID AND ARE DIFFERENTIALLY AFFECTED BY ALZHEIMER DISEASE Alzheimer's & Dementia. 15: P191. DOI: 10.1016/J.Jalz.2019.06.4518 |
0.575 |
|
| 2018 |
Self WK, Schoch KM, Alex J, Barthélemy N, Bollinger JG, Sato C, Cole T, Kordasiewicz HB, Swayze E, Bateman RJ, Miller TM. Protein production is an early biomarker for RNA-targeted therapies. Annals of Clinical and Translational Neurology. 5: 1492-1504. PMID 30564616 DOI: 10.1002/Acn3.657 |
0.473 |
|
| 2018 |
Sato C, Barthélemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Jockel-Balsarotti J, Sullivan M, Crisp MJ, Kasten T, Kirmess KM, Kanaan NM, Yarasheski KE, Baker-Nigh A, Benzinger TLS, Miller TM, et al. Tau Kinetics in Neurons and the Human Central Nervous System. Neuron. 98: 861-864. PMID 29772204 DOI: 10.1016/J.Neuron.2018.04.035 |
0.525 |
|
| 2018 |
Sato C, Barthélemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Jockel-Balsarotti J, Sullivan M, Crisp MJ, Kasten T, Kirmess KM, Kanaan NM, Yarasheski KE, Baker-Nigh A, Benzinger TLS, Miller TM, et al. Tau Kinetics in Neurons and the Human Central Nervous System. Neuron. 97: 1284-1298.e7. PMID 29566794 DOI: 10.1016/J.Neuron.2018.02.015 |
0.592 |
|
| 2018 |
Barthélemy NR, Li Y, Wang G, Fagan AM, Morris JC, Benzinger TLS, Goate A, Hassenstab J, Xiong C, Sato C, Bateman RJ, McDade E. P1-023: Mass Spectrometry-Based Measurement Of Longitudinal Csf Tau Identifies Different Phosphorylated Sites That Track Distinct Stages Of Presymptomatic Dominantly Inherited Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.024 |
0.375 |
|
| 2017 |
Barthélemy NR, Gabelle A, Sato C, Lehmann S, Bateman RJ. [P2-258]: HIGHLY SPECIFIC CSF TAU HYPERPHOSPHORYLATION ON T217 OCCURS SIMULTANEOUSLY WITH AMYLOIDOSIS Alzheimer's & Dementia. 13: P712-P712. DOI: 10.1016/J.Jalz.2017.06.911 |
0.538 |
|
| 2015 |
Sato C, Mawuenyega K, Barthelemy N, Patterson BW, Kasten T, Jockel-Balsarotti J, Chott R, Yarasheski KE, Miller TM, Bateman R. DT-02-04: Tau kinetics in the human cns Alzheimer's & Dementia. 11: P334-P335. DOI: 10.1016/J.Jalz.2015.08.160 |
0.533 |
|
| 2012 |
Sato C, Turkoz M, Dearborn JT, Wozniak DF, Kopan R, Hass MR. Loss of RBPj in postnatal excitatory neurons does not cause neurodegeneration or memory impairments in aged mice. Plos One. 7: e48180. PMID 23110206 DOI: 10.1371/Journal.Pone.0048180 |
0.696 |
|
| 2012 |
Sato C, Zhao G, Ilagan MX. An overview of notch signaling in adult tissue renewal and maintenance. Current Alzheimer Research. 9: 227-40. PMID 21605032 DOI: 10.2174/156720512799361600 |
0.306 |
|
| 2010 |
Takagi S, Tominaga A, Sato C, Tomita T, Iwatsubo T. Participation of transmembrane domain 1 of presenilin 1 in the catalytic pore structure of the γ-secretase. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15943-50. PMID 21106832 DOI: 10.1523/JNEUROSCI.3318-10.2010 |
0.559 |
|
| 2009 |
Hass MR, Sato C, Kopan R, Zhao G. Presenilin: RIP and beyond. Seminars in Cell & Developmental Biology. 20: 201-10. PMID 19073272 DOI: 10.1016/J.Semcdb.2008.11.014 |
0.54 |
|
| 2008 |
Sato C, Takagi S, Tomita T, Iwatsubo T. The C-terminal PAL motif and transmembrane domain 9 of presenilin 1 are involved in the formation of the catalytic pore of the gamma-secretase. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 6264-71. PMID 18550769 DOI: 10.1523/JNEUROSCI.1163-08.2008 |
0.55 |
|
| 2008 |
Tomita T, Sato C, Takagi S, Iwatsubo T. O4-03-03: C-terminal PAL motif of presenilin 1 comprises the subsite of gamma-secretase within the catalytic pore Alzheimer's & Dementia. 4: T189-T189. DOI: 10.1016/j.jalz.2008.05.520 |
0.503 |
|
| 2008 |
Takagi S, Sato C, Tomita T, Iwatsubo T. P4-208: Transmembrane domain 1 of presenilin 1 contributes to the formation of the catalytic pore of gamma-secretase Alzheimer's & Dementia. 4: T732-T732. DOI: 10.1016/j.jalz.2008.05.2276 |
0.522 |
|
| 2007 |
Isoo N, Sato C, Miyashita H, Shinohara M, Takasugi N, Morohashi Y, Tsuji S, Tomita T, Iwatsubo T. Abeta42 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate. The Journal of Biological Chemistry. 282: 12388-96. PMID 17329245 DOI: 10.1074/jbc.M611549200 |
0.581 |
|
| 2006 |
Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron. 52: 831-43. PMID 17145504 DOI: 10.1016/J.Neuron.2006.10.035 |
0.531 |
|
| 2006 |
Sato C, Morohashi Y, Tomita T, Iwatsubo T. Structure of the catalytic pore of gamma-secretase probed by the accessibility of substituted cysteines. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 12081-8. PMID 17108181 DOI: 10.1523/JNEUROSCI.3614-06.2006 |
0.56 |
|
| 2006 |
Sato C, Iwatsubo T. Focusing on beta-amyloid: report of the 35th Annual Meeting of the Society for Neuroscience. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 13: 114-6. PMID 16911967 DOI: 10.1080/13506120600722738 |
0.373 |
|
| 2006 |
Morohashi Y, Kan T, Tominari Y, Fuwa H, Okamura Y, Watanabe N, Sato C, Natsugari H, Fukuyama T, Iwatsubo T, Tomita T. C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester). The Journal of Biological Chemistry. 281: 14670-6. PMID 16569643 DOI: 10.1074/Jbc.M513012200 |
0.544 |
|
| 2006 |
Sato C, Barthélemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Kanaan NM, Benzinger TL, Miller TM, Karch C, Bateman RJ. O3-01-03: TAU KINETICS IN NEURONS AND IN THE HUMAN CNS Alzheimer's & Dementia. 14: P1008-P1009. DOI: 10.1016/J.Jalz.2018.06.2772 |
0.518 |
|
| 2006 |
Sato C, Watanabe N, Morohashi Y, Tomita T, Iwatsubo T. P3-416: Probing the structural changes of presenilin 1 by substituted-cysteine accessibility method Alzheimer's & Dementia. 2: S498-S498. DOI: 10.1016/j.jalz.2006.05.1687 |
0.477 |
|
| 2005 |
Watanabe N, Tomita T, Sato C, Kitamura T, Morohashi Y, Iwatsubo T. Pen-2 is incorporated into the gamma-secretase complex through binding to transmembrane domain 4 of presenilin 1. The Journal of Biological Chemistry. 280: 41967-75. PMID 16234244 DOI: 10.1074/jbc.M509066200 |
0.531 |
|
| 2004 |
Tomita T, Niimura M, Hayashi I, Sato C, Tanaka S, Shinohara M, Takahashi Y, Morohashi Y, Iwatsubo T. O3-05-04 Roles of presenilin cofactors in the assembly and activity of {gamma}-secretase complex Neurobiology of Aging. 25: S62. DOI: 10.1016/S0197-4580(04)80209-4 |
0.5 |
|
| Show low-probability matches. |